AlphaHelix Merges with Techtum Lab | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Swedish firms AlphaHelix Molecular Diagnostics and Techtum Lab have merged in an all-stock deal.

Under the terms of the deal, AlphaHelix will issue about 29.4 million shares of its stock at a price of SEK6.8 million ($1 million) to Labkompaniet, which owned Techtum. After the deal is completed, Labkompaniet will own a little less than 64 percent of the new company and shareholders of AlphaHelix will own the balance.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.